| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $327.3M | — | +36.5% |
| Cost of Revenue | $11.7M | — | +18.0% |
| Gross Profit | $100.8M | — | +27.6% |
| R&D Expense | $11.5M | — | -3.7% |
| SG&A Expense | $28.0M | — | -8.7% |
| Operating Income | $31.1M | — | +537.7% |
| Pre-tax Income | $22.9M | — | +254.8% |
| Income Tax | $5.7M | — | +332.6% |
| Net Income | $17.3M | — | +239.5% |
| EPS (Basic) | $1.25 | — | +235.9% |
| EPS (Diluted) | $1.22 | — | +232.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $85.5M | +5.5% | -32.3% |
| Accounts Receivable | $117.5M | +6.2% | +37.8% |
| Current Assets | $244.4M | +6.4% | -4.0% |
| Total Assets | $863.9M | +1.0% | +11.2% |
| Current Liabilities | $129.3M | -5.9% | -39.1% |
| Long-term Debt | $387.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $11.6M | — | +5601.0% |
| Investing Cash Flow | -$2.7M | — | +20.4% |
| Financing Cash Flow | -$4.4M | — | -118.7% |
| -0.2% |
| Total Liabilities | $559.1M | -1.7% | -17.0% |
| Stockholders' Equity | $304.7M | +6.3% | +193.7% |